VeriMomhexapeptide-45 est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications found (ECHA Annex VI) and no SCCS or CIR safety opinion specifically identifying reproductive hazards for hexapeptide-45. No peer‑reviewed reproductive or developmental toxicity studies located in PubMed for this ingredient; as a short peptide it is expected to have low dermal systemic absorption from cosmetic use (PubChem, CosIng). Based on these authoritative absences, default to no evidence of reproductive hazard. (Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, PubChem, CosIng.)
Related ingredients
Frequently asked questions
- hexapeptide-45 est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications found (ECHA Annex VI) and no SCCS or CIR safety opinion specifically identifying reproductive hazards for hexapeptide-45. No peer‑reviewed reproductive or developmental toxicity studies located in PubMed for this ingredient; as a short peptide it is expected to have low dermal systemic absorption from cosmetic use (PubChem, CosIng). Based on these authoritative absences, default to no evidence of reproductive hazard. (Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, PubChem, CosIng.)
- hexapeptide-45 est-il sûr pendant l'allaitement ?
- No data or regulatory flags (ECHA Annex VI, SCCS, CIR) indicating hazards for lactation or transfer into breast milk. No studies found in PubMed showing placental or milk transfer for hexapeptide-45; peptides of this size applied topically are generally poorly absorbed systemically (PubChem, CosIng), so breastfeeding exposure is expected to be negligible under normal cosmetic use.
- hexapeptide-45 est-il sûr pour la peau de bébé ?
- No evidence of infant-specific developmental or dermal toxicity (no SCCS/CIR/toxicology studies located). Hexapeptides are relatively large and polar, so adult dermal absorption is expected to be negligible (adult e=0), but because infant skin has higher surface‑area-to‑weight and an immature barrier, increase exposure rating by one (e=1) to reflect low but potentially measurable absorption in 0–3 yr skin. No data indicate increased hazard (h=0) or a specific reproductive mechanism (m=0).
- Comment VeriMom évalue-t-il hexapeptide-45 ?
- VeriMom évalue hexapeptide-45 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à hexapeptide-45 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à hexapeptide-45 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.